Tuesday, May 21 2013 9:47 AM EDT2013-05-21 13:47:14 GMT
We are thrilled to share an update on a Sulphur teen with a rare disease that we introduced you to in March.Brother and sister, Sam and Sydni Dupre, have Friedreich's Ataxia. This is a disease threateningMore >>
Sam Dupre of Sulphur had the Lake Charles Civic Center crowd on its feet as he moved his wheelchair aside and walked across the stage to receive his diploma.More >>
Tuesday, May 21 2013 9:33 AM EDT2013-05-21 13:33:07 GMT
A four-year-old Bell City boy has just been diagnosed with a deadly disease that is causing him to go backwards in development. Speaking, chewing, swallowing, seeing and walking were once thoughtlessMore >>
Four-year-old Coy Fruge of Bell City has been diagnosed with a deadly disease that is causing him to go backwards in development. KPLC's Britney Glaser shares his story in this "Faces of Rare Disease." More >>
Tuesday, May 21 2013 7:30 AM EDT2013-05-21 11:30:29 GMT
It's not the scenario the Cameron Parish School Board thought they would be facing. "I would like to say that I'm ashamed of Cameron Parish. They voted to pass the road and bridge and the health unitMore >>
The Cameron Parish School Board is searching to offset nearly $4 million after voters decided not to renew to tax propositions earlier this month. As KPLC's Lee Peck reports, while they're set to give it another try, they'll have to find a way to cut costs in the meantime.More >>
Tuesday, May 21 2013 6:57 AM EDT2013-05-21 10:57:10 GMT
The Sunrise Facebook friend of the day for Tuesday, May 21 is Gail Fitzgerald from Grand Lake. If you'd like the chance to be our next Facebook friend of the day, just like the Sunrise Facebook pageMore >>
The Sunrise Facebook friend of the day for Tuesday, May 21 is Gail Fitzgerald from Grand Lake. More >>
Local News, Weather, Traffic, Sports, Stocks, Movies on your Cell PhoneMore >>
Get local news, weather, sports, and video on your mobile device.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Plato BioPharma, Inc.
WESTMINSTER, Colo., March 19, 2013 /PRNewswire/ -- Plato BioPharma, Inc. (PBI) will be presenting their integrated pharmacology capabilities at the "PKPD Summit Boston" in Boston, Massachusetts on March 20, 2013. The presentation will overview PBI's integrated pharmacology approach. The presentation will be delivered by Drs. Glenn J. Smits, PhD and Craig F. Plato, PhD, President of Plato BioPharma, Inc.
"Clients trust PBI to deliver complex preclinical proof of concept studies due to our extensive industry experience in disease modeling and discovery pharmacology. We're participating in the PKPD Summit to detail our broader capabilities and expertise in drug discovery. We appreciate the challenges of translating preclinical work, and believe PBI is well-positioned to address these challenges and provide disease-relevant PK and PD approaches. We strive to bring a more creative and partnering approach to the preclinical paradigm to deliver the highest quality science while decreasing the time for enabling decisions thus minimizing cost," said Dr. Plato.
Founded in 2009, Plato BioPharma, Inc. is a leading preclinical contract research organization (CRO). The company offers expert drug discovery and development capabilities in cardiovascular, renal, pulmonary, and hepatic disease therapeutic areas. PBI provides an integrated research platform from the in-life phase through clinical chemistry, biomarker and histological analyses. The company specializes in custom study design and execution of engagements ranging from pharmacokinetics through disease model development and proof-of-concept evaluation. PBI is headquartered in Westminster, Colorado.